Nasal Sinus Leiomyosarcoma in a Patient with History of Non-Hereditary Unilateral Treated Retinoblastoma

被引:12
作者
Fitzpatrick S.G. [1 ]
Woodworth B.A. [2 ]
Monteiro C. [3 ]
Makary R. [3 ]
机构
[1] Department of Oral and Maxillofacial Diagnostic Sciences, University of Florida College of Dentistry, Gainesville, FL 32610
[2] Department of Surgery/Division of Otolaryngology, University of Alabama, Birmingham, AL
[3] Department of Pathology, University of Florida College of Medicine, Jacksonville, FL
关键词
Leiomyosarcoma; Retinoblastoma; Secondary malignancy; Sinonasal;
D O I
10.1007/s12105-010-0207-1
中图分类号
学科分类号
摘要
Hereditary patients with a history of treated retinoblastoma (RB) have a greatly increased risk of a broad spectrum of secondary malignancies appearing many years later, with a high incidence in the head and neck region. Leiomyosarcomas (LMS) account for up to 58% of these tumors. LMS in the sinonasal region generally are uncommon and are associated with a locally aggressive course and have a poor prognosis. RB may occur in two forms. The hereditary form is generally bilateral but can present unilaterally with a positive family history and typically exhibits a germline mutation in the RB1 gene on chromosome 13. The non-hereditary form is usually unilateral but can show the same germline mutation in up to 10% of cases. Patients with hereditary RB have been shown to have a significantly higher cumulative risk of developing secondary malignancies than those with the non-hereditary form (28 vs. 1.44% respectively). Most reported cases of sinonasal LMS are in patients with a history of the bilateral hereditary form of treated RB. We report a case of LMS of the nasal sinus area in a 35-year-old African American male with a history of non-hereditary unilateral RB and radiation therapy. To the best of our knowledge, this is the first reported case of sinonasal LMS arising in a patient with a history of non-hereditary unilateral RB. The clinical history, radiology, and pathology are presented along with a brief discussion of the literature. © 2010 Humana.
引用
收藏
页码:57 / 62
页数:5
相关论文
共 28 条
  • [1] Kleinerman R.A., Tucker M.A., Abramson D.H., Et al., Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma, J Natl Cancer Inst, 99, pp. 24-31, (2007)
  • [2] Maccarthy A., Bayne A.M., Draper G., Et al., Non-ocular tumours following retinoblastoma in Great Britain 1951 to 2004, Br J Opthamol, 93, pp. 1159-1162, (2009)
  • [3] Ulrich C.T., Feiz-Erfan I., Spetzler R.F., Et al., Sinonasal leiomyosarcoma: review of literature and case report, Laryngoscope, 115, pp. 2242-2248, (2005)
  • [4] Dunkel I.J., Gerald W.L., Rosenfield N.S., Et al., Outcome of patients with a history of bilateral retinoblastoma treated for a second malignancy: the memorial sloan-kettering experience, Med Pediatr Oncol, 31, pp. 59-62, (1998)
  • [5] Acquaviva A., Ciccolallo L., Rondelli R., Et al., Mortality from second tumour among long-term survivors of retinoblastoma: a retrospective analysis of the Italian retinoblastoma registry, Oncogene, 25, pp. 5350-5357, (2006)
  • [6] Marees T., Molle A.C., Imhof S.M., Et al., Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up, J Natl Cancer Inst, 100, pp. 1771-1779, (2008)
  • [7] Fletcher O., Easton D., Anderson K., Et al., Lifetime risks of common cancers among retinoblastoma survivors, J Natl Cancer Inst, 96, pp. 357-363, (2004)
  • [8] Kleinerman R.A., Tucker M.A., Tarone R.E., Et al., Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up, J Clin Oncol, 23, pp. 2272-2279, (2005)
  • [9] Martin-Hirsch D.P., Habashi S., Benbow E.W., Et al., Post-irradiation leiomyosarcoma of the maxilla, J Laryngol Otol, 105, 12, pp. 1068-1071, (1991)
  • [10] Rubin C.Z., Rosenfield N.S., Abramson S.J., Et al., The location and appearance of second malignancies in patients with bilateral retinoblastoma, Sarcoma, 1, pp. 89-93, (1997)